Phosphate and 1alpha-hydroxyvitamin D3 therapy in haemodialysis patients.
D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood; D002114:Calcinosis / Q000209:etiology; D002118:Calcium / Q000378:metabolism; D003316:Corneal Diseases / Q000209:etiology; D005260:Female; D006801:Humans; D006887:Hydroxycholecalciferols / Q000009:adverse effects / Q000627:therapeutic use*; D007408:Intestinal Absorption; D007676:Kidney Failure, Chronic / Q000150:complications; D008297:Male; D010281:Parathyroid Hormone / Q000097:blood; D010710:Phosphates / Q000378:metabolism*; D011537:Pruritus / Q000209:etiology; D006435:Renal Dialysis
D006887:Hydroxycholecalciferols; D010281:Parathyroid Hormone; D010710:Phosphates; D000469:Alkaline Phosphatase; D002118:Calcium